SmallCap Hunter : Trying to find the dark horses with triggers

Q&A: Questions & Answers Portfolio Q&A
208

This issue was spoken of in the Q1FY22 con-call and I have myself been critical of the move but here’s the perspective of management:-

  1. We were talks with these for last 1/2 years;
  2. Not sure if the rights would have been subscribed (management sounded skeptical)
  3. Said they’ll consider rights in future fund raising requirements
  4. No further immediate funding requirements, so no further dilution.

And yes, the pricing is as per SEBI norms, it looks very low because the stock had a sharp upmove from 130 levels.

Not very satisfied, but then, not every thing is perfect. One has to weigh risks / rewards here.

2 Likes